1[1]Vander D R, Eberhardt R, Derr I, et al. Treatment of chronic stable angina with carvedilol in comparison with nifedipine. Eur Heart J, 1991, 12:60～64.
2[2]Nahrendorf W, Rading A. A comparison of carvedilol with a combination of propranolol and isosorpide dinitrate in the chronic treatment of stable angina. J Cardiovasc Pharmacol, 1992, 19(Suppl Ⅰ):114～116.
3[3]Hauf-Zachariou U, Pfarr E, Vander D R. Carvedilol in comparison and in combination with isosorbide dinitrate sustained in patients with chronic stable effort-induces angina pectoris. Clin Drug Invest, 1997, 14:465～473.
4[4]Wendt T, Vander D R, Schrader R, et al. Acute hemodynamic effects of the vasodilation and β-blocking agent carvedilol in comparison to propranolol. J Cardiovasc Pharmacol, 1987, 10 (Suppl Ⅱ):147～150.
5[5]Vander D R, Eberhardt R, Derr I, et al. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.J Cardiovasc Pharmacol, 1992, 19(suppl): 122～127.
6[6]Vander D R, Hauf Z U, Pfarr E, et al. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris. Am J Cardiol, 1999, 83:643～649.
7[7]Jacob S, Rett K, Wickmagr M, et al. Differential effect of chronic treatment with two β-blocking agents on insulin sensitivity: the carvedilol-metoprolol stady. J Hypertens, 1996, 14:489～494.
3Shu de F, Dong BR, Lin XF,et al. Long-term beta blockers for stable angina: systematic review and meta-analysis[J].European journal of pre- ventive cardiology, 2012, 19(3):330-341.
